FOLLOW US

  • facebook
  • twitter
Tue

March 16, 2026

Slate Medicines Raises $130 Million Series A

America February 24, 2026

Slate Medicines Raises $130 Million Series A to Advance Anti-PACAP Monoclonal Antibody for Migraine Prevention

Slate Medicines Inc., a Raleigh, North Carolina-based biotechnology company focused on next-generation treatments for headache disorders, announced Tuesday it has…

By Rachel Moore

MiniMed Group $742 million IPO

America February 24, 2026

Diabetes Tech Giant MiniMed Group Files for $742 Million IPO

MiniMed Group, the diabetes-focused subsidiary of Medtronic, filed plans Monday with U.S. regulators to raise approximately $742 million in an…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter